Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pelvic Organ Prolapse
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to prospectively assess the outcomes of robotic sacrocolpopexy for repair of pelvic organ prolapse in high volume european centers.

Provided treatments

  • Procedure: Robotic assisted sacrocolpopexy (RASC)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01598467. The sponsor of the trial is Femke van Zanten and it is looking for 300 volunteers for the current phase.
Official trial title:
Prospective Interventional Study on Robotic Sacrocolpopexy: a European Multicentric Cohort (PARSEC)